GlassScriptPhysician profile
Mohammad Elomari
NPI 1831709153
$1,488.12
in general payments reported to CMS, 2019-2025
12 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $346 · 2023: $550 · 2024: $331 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.13 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $316.45 | 2022-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $218.08 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $216.51 | 2023-2024 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $191.43 | 2022-2023 | Camzyos |
| Amgen INC. | $127.15 | 2022-2024 | Repatha |
| Bridgebio Pharma, INC. | $124.46 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $101.60 | 2025 | Winrevair |
| Boston Scientific Corporation | $77.40 | 2023-2024 | Watchman Access System, Varithena Administration Pack |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.46 | 2022-2023 | Lifevest |
| Lantheus Medical Imaging, INC. | $20.44 | 2024 | |
| Chiesi USA, INC. | $20.03 | 2022 | |
| Pfizer INC. | $16.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Elomari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.